Analyst Harsh Words Spacex Casts Doubt on IPO Prospects
A leading analyst questions SpaceX's IPO math and governance, casting doubt on the deal's potential for investors. He...
This intro contrasts SP 500 with target date funds, highlighting flexibility, fees, and potential growth paths relevant to retirement planning.
27,405 articlesA leading analyst questions SpaceX's IPO math and governance, casting doubt on the deal's potential for investors. He...
A major fund just raised its stake in a leading data-center company. This article breaks down what that move could me...
Bitcoin steadies near key levels as risk appetite returns amid mixed geopolitical headlines. This guide breaks down t...
A newly clarified rule lets unused 529 college-savings money roll into a Roth IRA, potentially producing substantial,...
A family debates paying elderly parents $1,000 a month for babysitting, but opts to fund an investment for the parent...
Investors eye the physical ai’s trillion opportunity—a potential $50 trillion payoff from industrial AI—but it requir...
When a fund exits its Brookdale Senior Living stake, it raises questions about momentum and risk. This guide breaks d...
A big investment firm has exited its complete stake in a biotech company, disclosed in an SEC filing. The move provid...
A prominent fund dumped its monday.com stake in a move that coincided with a steep stock decline. This article breaks...
A 58-year-old accountant tests whether a portfolio built on JEPI and SPYI can replace a $90,000 salary. The plan hing...
A prominent on-chain researcher raised alarms about AscendEX withdrawal processing, with users reporting multi-day de...
When a big investor exits a biotech stock, it rattles the market and raises questions. This deep dive explains the 'f...